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Inflammatory Bowel Disease affects more than 300,000 people in 
the UK.  Many innovative solutions are being developed in this area 
in Scotland. These solutions range from clinical support tools and 
applications to support self-management to the production of digitally 
accessible trusted information.  In November 2018 representatives 
from the NHS, government, third sector and commercial companies 
were brought together to share what they were working on. The aim 
of the day was to identify areas where participants could collaborate, 
ultimately improving the innovations available in this field.
 
The workshop was instigated by NHS Scotland and was designed and 
delivered by a team of designers from the Digital Health and Care 
Institute. This report describes the outputs form the day.
 
Elizabeth Brooks
Design Director, DHI
Forword 
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Summary
In November 2018 the Scottish 
Government funded Modern 
Outpatient Programme 
brought together a number of 
individuals, companies and third 
sector organisaitons currently 
engaged in digital innovations 
for Inflammatory Bowel Disease 
(IBD) patients and the clinicians 
supporting them. Each innovation 
was asked to supply information 
for a poster summarising their 
work before the workshop. 
These were available at the 
workshop and are included in this 
report. During the workshop the 
participants collectively mapped 
out their IBD products which 
aimed at supporting primary care, 
secondary care, community care, 
and patients to better manage 
this long-term condition. 
Following an exhibition of 
the posters and a number of 
demonstrations provided by 
participants, the group each 
defined and mapped their idea 
in the context of a typical patient 
pathway for someone diagnosed 
with an IBD related condition.  
The mapping exercise aimed 
to illustrate any overlaps 
or complimentary areas of 
deployment in the systems being 
described by the participants. The 
map template which was adapted 
for this workshop was based 
on a generic patient pathway 
developed by Crohn’s and Colitis 
UK. The map included an area for 
systems aimed at patients and an 
area for those aimed at clinicians. 
Each innovation was then 
mapped to the area in the patient 
pathway it aimed to serve.
In the course of the mapping 
it was recognised that some 
innovations aimed to offer 
an underpinning technical 
architecture which would serve 
the length of the patient pathway. 
In the same way, some providers 
of information also aimed to 
support the patient from the start 
to the end of the pathway. 
A number of the innovations 
serve the interface between 
primary and secondary care 
supporting referral and vetting. 
Splitting innovations into whether 
they offered an IT solution or 
content helped highlight possible 
areas of collaboration.  
The mapping highlighted a 
number of common areas 
including the value of good 
quality, easy to access, self-
management support for 
patients. The group also touched 
on innovation opportunities 
in artificial intelligence made 
possible by the availability good 
quality IBD data. 
It was recognised that digital 
technology can enhance and 
improve the patient experience 
as the NHS supports their self-
management of this condition. 
The illustration of the IBD map 
that follows summarise each 
innovation as it was mapped 
onto the typical patient pathway. 
Included in the summary 
are a sort description of the 
product or idea, its aim, and its 
stage of development. Some 
questions were also raised during 
discussions around the mapping, 
these are presented in this report 
as points for further discussion.  
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Video prescription 
Grampian, Ayrshire and Arran
Scoping for the project will be 
completed in 2018 
Information to support patient 
Information stored by patient 
Link to Quality Assurance 
Framework
SUMMARY CONTENT
OPPORTUNITYSTAGE
Flare up care - accessible to 
patient 
Information to support patient
Care plan could be digital with 
focus on delivery
Two tools in production stage & pilot 
versions expected by end of 2018
SUMMARY CONTENT
OPPORTUNITYSTAGE
Patient generated data - 
symptom entry & tracker
30 patients currently, ready for roll out 
using, 800 patients registered in Salford
Information for self 
management patient data
Link to Quality Assurance 
Framework
SUMMARY CONTENT
OPPORTUNITYSTAGE
Video consultation and waiting 
room
IT delivery platform,
No content. 
Possible future collaboration 
with NHS 24
Pilot running with NHS Scotland 
for 2 years
SUMMARY CONTENT
OPPORTUNITYSTAGE
Management information for 
patients
Information to support patient
Information to support clinician 
Trail in primary care
App - ﬁnal stages of development
SUMMARY CONTENT
OPPORTUNITYSTAGE STAGE
Development of data base 
Currently England only 
Accreditation in England 
Clinical, patient, and related 
data  
SUMMARY CONTENT
STAGE
Research and focus group stage 
STAGE
Live product
STAGE
Supports clinical vetting of 
referral
Currently paperbased but 
moving to IT
Content and IT delivery system  
SUMMARY CONTENT
STAGE
IT system support patient through referral 
Provide information and expectations 
from patient 
Patient online booking system 
with reminders 
Project is in development 
Also involved in 7
SUMMARY CONTENT
NOTE
guidance on how to prepare for 
appointments & tips on self management
Accredited information
Link to NHS inform 
SUMMARY CONTENT
OPPORTUNITY
Signposting to resources 
Care plan & ﬂare
Research and focus group stage
Link to NHS inform 
SUMMARY CONTENT
OPPORTUNITY
Content developed by GPs for 
GPs at both initial contact with 
patient and ongoing care.
Tools to support GPs to 
diagnose and support patients 
SUMMARY CONTENT
Patient facing tools platform
Flexible open approach 
About to go live with patients, 
in use in other areas
Provided by Clinicians
Patients tracking symptoms
System’s design allows for other innovations 
to be surfaced to patients via the platform.
SUMMARY CONTENT
OPPORTUNITYSTAGE
Live project in second year
STAGE
Digital product for 
self-management of IBD
Live in Highland, pilot in Tayside
Kicked oﬀ in Oct 2018
Connecting apps to the IBD 
registry
Pilot
Patient recorded data 
Prompts for patients 
patient information for 
dieticians
SUMMARY CONTENT
STAGE
Automated triage of GP 
referrals using NLP 
Communication and IT delivery 
system
SUMMARY CONTENT
STAGE
Patient collected data to be 
input into 6
Recognised international 
standards considered
SUMMARY CONTENT
OPPORTUNITYSTAGE
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There are a lot of current innovation projects that 
have the potential to greatly improve IBD services 
in the future.  These include both internal service 
improvements, and projects led by external 
organisations.  This means the innovation landscape 
can appear very confusing and even disjointed, and 
it makes it harder to identify potential opportunities.
This mapping exercise was intended to help reduce 
that confusion.  It was designed to give everyone a 
good understanding of the current landscape, and 
to allow them to identify potential links, overlaps or 
gaps between the various projects.
 
This work will be taken forward in two ways.  Firstly, 
it is hoped that the individuals and organisations 
working in this area will use this report as a 
key reference, to identify potential areas of 
collaboration, or best practice, or to allow them to 
better focus their efforts and avoid any unwarranted 
overlap with other innovations. 
 
Innovation can be supported and guided, but 
it cannot be mandated.  The mapping exercise 
was designed to identify opportunities for future 
innovation, but it will be up to the individual 
companies involved in this work to decide if, and 
how, they wish to exploit those opportunities. 
Further discussion
During the mapping two key questions were raised relating to the 
provenance and reliability of information, and transforming data into 
useful applications that improve patient experiences. 
Validation
There is lots of information available for patients and carers, can this 
information be kite marked? 
Intelligent systems
With all the data available on IBD, how to we link the AI to the 
other processes we have been discussing, for example patient 
questionnaires? 
The second way this work will be taken forward is by 
helping the Scottish Government and NHS Boards 
overseeing innovation work in this field to better 
understand where there is a need to build stronger 
links between projects, or where work should be 
refocussed to avoid inappropriate duplication.  This 
report is designed to inform the direction of future 
innovation, by identifying areas that are not the 
focus of current improvement efforts and ensuring 
that future projects are aware of the current 
landscape and will not conflict with existing work.
 
This work is at an early stage, but initial steps have 
included working with National Services Scotland to 
ensure that all these innovations are included on the 
national Health Innovation Advisory Portal (HIAP), 
and building links with national innovation forums, 
such as the Health and Social Care Innovation 
Network and the NHS Test Board Governance 
Group.
 
I would like to thank all participants for their help 
and willingness to support this work.  By working 
together, we can ensure that current innovation 
work will play a key role in supporting the 
development of joined-up, patient-focussed IBD 
services.  By doing so, we can help provide a better 
experience for people with IBD across Scotland.
 
Next Steps
David Pratt
National Improvement Advisor
Directorate for Health Performance and Delivery
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NO DELAYS 
INFORMATION 
PLATFORM
1.
Clinical Users: The platform 
allows clinical users to email 
bespoke video and other content 
directly to patients.  The platform 
also allows the clinician to 
check if the patient has viewed 
the package of information 
‘prescribed’ to them.
Patient Users: Patients receive a 
link to the information selected 
by the clinical team and can view 
this whenever they want and 
as often as they wish.  They can 
share this with family/carers as 
appropriate.
•Scope, specify and upgrade 
internet-based platform. 
•Work with clinical teams 
to review and test existing 
packages of video-based 
content in the context of  
the Patient Pathway and, where 
appropriate, develop new 
content.
•Review the functionality 
and potential of the No 
Delays product to support 
other workstreams e.g. NHS 
Inform on line facility, Vetting 
Information Plus digital project 
etc.
No Delays has the potential to 
support the redesign of Patient 
Pathways to reduce the need 
for traditional face to face 
appointments by providing 
video-based information and 
other content created by the 
clinical team.  Clinical teams 
are supported to collaborate on 
the production of content and 
this ensures that information 
provided to patients is consistent 
and reflects current local practice. 
No Delays is a key enabler for self-
management through provision 
of video-based information on 
medicines management, medical 
equipment use, pre and post 
op exercise regimes and can 
also help patients prepare for 
appointments, treatment or 
procedures. 
Stabilise the No Delays platform 
and upgrade functionality 
Explore the potential of No 
Delays to facilitate the redesign 
of Pathways to reduce the need 
for face to face contact with a 
view to rolling out for nationwide 
utilisation on a ‘Once for 
Scotland’ basis.
For further details contact Aileen.MacVinish@nhs.net (Project Manager) or Jamie.
Hogg@nhs.net (Clinical Lead) 
Demo site: www.nodelays.co.uk and sign in using email address demo@nodelays.
co.uk and password bluesky
The Scottish Access Collaborative.
Scoping for the project will 
be completed in December 
2018 and the upgrade to the 
platform will be complete 
approximately 16 weeks from 
commencement.  The project 
team will be consulting with 
partners and aligned projects to 
ensure connectivity and also to 
maximise opportunities to deliver 
improvements at scale.
No Delays started as a research 
and development project in 
2014 and the prototype platform 
was developed in consultation 
with clinicians and patients.  
The system has been in active 
use by nurses, AHPs, GPs and 
Consultants over the past 4 years. 
A wide range of clinical teams 
has been involved in reviewing 
Pathways and developing the 
video-based content and patients 
have also contributed directly by 
committing their  
story to film.
IBD innovation posters
In preparation for the workshop, individuals, companies and third sector 
organisations currently engaged in digital innovations for Inflammatory 
Bowel Disease (IBD) patients and the clinicians supporting them were 
invited to supply information for a poster summarising their work. The 
following section is the collection of these posters which are numbered 
to match the previous visual summary. 
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SCOTLAND WIDE 
GUIDED SELF-
MANAGEMENT 
FOR IBD
2.
Adults living with Crohn’s Disease 
and ulcerative colitis in Scotland 
and NHS IBD services in Scottish 
hospitals. Staff in Primary Care 
are also expected to benefit from 
using the tools. After the testing 
stage, the intention is for the 
tools for be made available across 
the UK via the Crohn’s and Colitis 
Companion:
https://companion.
crohnsandcolitis.org.uk/
•Build on the findings of Crohn’s and 
Colitis UK’s scoping exercise, “What 
Self-Management means for people 
with IBD” which looked at what 
matters to people with IBD and HCPs 
and produced a position statement 
setting out the vital components of 
self-management for IBD.
•Co-design self-management 
tools via a multi-stakeholder co-
design workshop. This led to the 
development of two distinct ideas for 
self-management tools; a ‘flare-card’ 
and an individualised care plan.
• Run a small test of change using pilot 
versions of the tools with around 100 
patients in 3 or 4 sites. Evaluate and 
refine the tools with a view to rolling 
them out nationally in 2019.
The project will help to support most, if 
not all of the ‘vital components’ of self-
management of IBD, i.e.
• A responsive IBD service that is easy 
to access when needed
• IBD services with resources to support 
self-management 
• IBD HCPs who are confident 
and knowledgeable about self-
management 
• Good relationships between 
people with IBD and Health Care 
Professionals 
• Good quality information and 
support for people with IBD to feel 
empowered and in control
• Access to tools, plans and support to 
manage treatments, symptoms, and 
flare-ups
• Access to emotional and psychological 
support 
• Access to e-health and technology 
resources.
These components were developed by 
in response to feedback from patients 
and HCPs about what matters to them 
in relation to self-management of IBD.
One of the recommendations of 
the National Blueprint for IBD 
in Scotland is to “co-design and 
develop a Scotland-wide self-
management programme”. The 
aim of the project is to produce 
national self-management 
resources.
Elaine Steven, Health Services Development Manager, Crohn’s and Colitis UK - elaine.
steven@crohnsandcolitis.org.uk;  Nancy Greig, Health Policy and Public Affairs Officer, 
Crohn’s and Colitis UK - nancy.greig@crohnsandcolitis.org.uk 
https://www.crohnsandcolitis.org.uk/
Initial funding is via the Modern 
Outpatient Programme with 
ongoing funding from Crohn’s 
Both products are at the 
preproduction stage, with pilot 
versions expected to be available 
for testing by the end of 2018.
The project has been co-produced with 
the Modern Outpatient Programme 
via a working group of patients, IBD 
clinicians (including gastroenterologists, 
nurses, dietitians), a GP and staff from 
Crohn’s and Colitis UK. The co-design 
workshop in May 2018 was attended 
by 25 people and draft versions of the 
both tools have been further refined 
by a remote working group of key 
stakeholders.
Patients and clinicians will be involved in 
testing both tools and providing further 
feedback. The test of change in NHS 
Borders will be included in a patient 
engagement plan for a wider service 
improvement project.
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MY IBD 
PORTAL
3.
Salford Royal NHS Foundation 
Trust and  Royal Free NHS Trust.
• Development of a personalised 
health record containing 
disease specific information and 
investigation results.
•  Development of a  
self-management component 
advising how to manage 
relapsing disease.
• Links to Crohn’s  
and Colitis companion.
Enhances self-management patients 
have the power to handle their 
condition more confidently and 
effectively and to take more decisions 
for themselves.
Improved communication providing 
patient access to their personal 
health records at any time, any place 
with secure email and access across 
health communities will enhance 
communication. 
Enhanced shared decision-making 
patients feel more confident dealing 
with clinicians and the NHS through a 
more equitable patient-professional 
partnership where information and 
power  
is shared. 
Education tailoring bite sized 
information to the patients’ personal 
health record will provide a more 
individualised service and has the 
potential to lead to positive health 
behaviour changes e.g. better 
compliance  
The aim of the project was to 
improve patients access to their 
health record and improve the 
quality of educational resources 
to improve knowledge related to  
their IBD.
http://www.patientview.org/
Crohn’s and Colitis Living with IBD 
research award.
Fully operational for five years.
Full research evaluation at 12 
months and 2 years.
Crohn’s and Colitis UK
Salford Royal NHS Foundation 
Trust –  
Professor J McLaughlin, Cath 
Stansfield,  
Dr. Chris Calvert
Solid State - Nadim Yazdani
Patient View – Neil Turner
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ATTEND 
ANYWHERE
4.
Patients across Scotland who  
would normally require a  
face-to-face appointment. At the 
moment this is limited to pilot 
sites in multiple Boards.
A web-based platform that allows 
NHS Boards to offer video-call 
appointments to patients instead  
of a face-to-face appointment  
when appropriate.
Patients will not have to travel 
unnecessarily. It will provide 
them with a more convenient, 
comfortable method of having a 
clinical appointment.
A web-based platform that allows 
NHS Boards to offer video-call 
appointments to patients instead  
of a face-to-face appointment  
when appropriate.
Dawn Robb, Project Manager - dawn.robb1@nhs.net
https://sctt.org.uk/programmes/video-enabled-health-and-care/attendanywhere/ 
Intention is that a national 
license for Attend Anywhere will 
be purchased by NHS Scotland, 
allowing national access to  
the system.
Product is live and well 
established in Australia. NHS 
Scotland has been piloting it for 
approximately 2 years and is 
currently trying to scale up this 
work. Work overseen by NHS NSS 
project team.  There are local 
implementation teams in all pilot 
NHS Boards.  Work is supported 
by the Scottish Government 
(through policy, finance and 
implementation).
AIMED AT
OVERALL AIM
CONTACT 
DETAILS
PROJECT 
SUMMARY
STAGE
BENEFIT FOR
PATIENT CARE
DEVELOPMENT
FUNDING
DECISION 
SUPPORT 
FOR NEW GI 
PATHWAYS
5.
•GPs, dietitians, practice nurses  
and ANPs, junior doctors and 
senior secondary care clinicians 
who do not specialise in GI 
conditions.
•Patients and carers.
This development supports:
• Improved patient experience.
• More efficient use of health 
service resources.
• Shared decisions with stronger 
patient and carer participation.
• More timely, safe and 
appropriate patient care.
• Better coordination of care 
across primary and secondary 
care interface.
• Moving to greater equity of 
service across Scotland.
To improve experience of  
people with IBS, IBD and 
Coeliac Disease, by facilitating 
implementation of pathways that 
maximise effective use  
of primary and community care  
and self-management  
and prevent unnecessary  
outpatient appointments.
Ann.wales@gov.scot
Modern Outpatient Programme
Clinical leads (medical and 
dietitian) for  
GI Modern Outpatient 
Programme 
GP workshops 
Leading charities 
NHS 24
1) Providing healthcare 
professionals across the whole 
multidisciplinary team, in 
primary and secondary care, with 
quick and easy access to new 
assessment and management 
pathways.
2) Providing patients and carers 
with information on management 
and self-management of their 
conditions, to support self-
management and shared 
decision-making.  This is based 
largely on signposting to high 
quality information sources such 
as NHS Inform and major charity 
websites.
This information is delivered 
through 3 routes:
• Mobile app which equally 
supports professionals and 
citizens.
• Website version of the mobile 
app.
• Embedding pathways in primary 
care electronic health record 
systems to support clinical 
decision-making and shared 
decisions in  
the consultation.
STAGE
End-user testing in test 
environments
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IBD REGISTRY
6.
Primarily patients and clinicians, 
through better information 
returned, but also clinicians and 
groups with a focus on quality 
improvement, and also  
NHS managers. 
• Working with sites to capture 
data, providing them tools and 
support they need, including a 
secure web-based clinical data 
capture system.
• Working with specialists such 
as the University of Liverpool’s 
Biostatistics Department to 
analyse and report on the data 
collected.
• Working closely with key 
stakeholder groups to identify 
how the data we collect can  
be best analysed, presented 
and put to use to help achieve 
our aims.
• By supporting the IBD Standards 
movement by presenting the 
trending metrics that show how 
clinical treatment is moving 
towards these goals.
• By providing localised data 
back to sites, benchmarked 
against national data, that helps 
to inform and improve their 
services.
• By providing a rich research 
environment, both in terms of 
data and research facilitation.
To improve care and outcomes 
for IBD patients and clinical 
teams across the UK by building a 
pseudonymised linked database 
of clinical, patient and related 
data.
Our website is www.ibdregistry.org.uk  
Please contact the IBD Registry for more information on support@ibdregistry.org.uk
The Registry has been growing 
since 2012, but is now in its 
6th month as an independent 
company.  We are looking 
forwards to 2019 as the year 
that we can really start to grow 
in achieving our aims as an 
independent company.
The IBD Registry is now an 
independent non-profit, 
governed by member 
organisations the British Society 
of Gastroenterology, the Royal 
College of Physicians and 
Crohn’s and Colitis UK.  We are 
very grateful for the BSG for 
supporting development of the 
Registry in its early and growing 
years.
FUNDING
The IBD Registry is financially 
self-sustaining, with a diversified 
range of income sources, 
including grants, quality account 
service income, research 
infrastructure and support fees, 
and is looking to follow the role 
of other Registries in using its 
knowledge and infrastructure 
to provide a pharmacovigilance 
service for newly released 
medications.
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VETTING 
(REFERRAL) 
INFORMATION 
PLUS
7.
All new referrals to outpatient 
services
•Collect clinical information 
earlier in the patient referral 
journey with appropriate 
education.
 
•Streamline referral pathway 
includes empowering patient 
with knowledge of stage of 
referral and options at each 
stage.
•Reduce reliance on outpatient 
clinic to gain specialist clinical 
details.
Change focus of patient referral 
pathway to be more patient 
focussed empowering the patient 
to make choices for their health.
Capture patient data at the point 
of referral to streamline the 
patient journey from referral to 
diagnosis
Modern Outpatient Program
Digital solution currently in 
development with paper based  
solution in pilot.
Currently progressing as part of 
the Modern Outpatient program 
of work
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PATHFINDER 
(ONLINE 
APPOINTMENT 
BOOKING & TRIAGE) 
VIP (VETTING INFO 
PLUS) 
8.
Patients who have been referred 
for an outpatient appointment.
• Online appointment booking 
with automated reminders.
•  Active Clinical Referral Triage 
(online questionnaire + online 
education + “managed” 
patient requests for help). 
Improved patient experience. 
Eliminate the “radio silence” that 
patients typically experience 
while awaiting an outpatient 
appointment
Better-informed patients
Flexibility in choice of dates.
Ultimately shorter waiting times 
if unnecessary appointments are 
reduced.
Our project aims to reduce  
waiting times. It does so by 
reducing the number of wasted 
appointment slots (from DNAs) 
and by reducing the number 
of unnecessary face-to-face 
appointments (e.g. where the 
patient could be better handled 
without the need for  
a f2f appointment).
martin@lumerahealth.com
Scottish Government
Both projects are currently under 
development. 
Modern Outpatient Programme 
(Scottish government)
NHS Grampian
NHS GGC
NHS Fife
Civtech
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PATIENT 
EMPOWERMENT 
GUIDE
9.
People living with Crohn’s Disease 
or Ulcerative Colitis.  
 
Useful for both newly diagnosed 
patients and those living with the 
condition for some time.
• Provide guidance on  
how to prepare for an 
appointment, including  
how to set goals, ask relevant 
questions, and use the  
time wisely.
•  Provide tips on  
self-managing your condition, 
including symptom tracking.
Patients will be better equipped 
to self-manage their conditions, 
including managing symptoms 
at home, thereby reducing need 
for clinic and emergency visits. 
The guide will also help them 
understand how to get the most 
out of appointments with their 
IBD team, making more efficient 
use of clinic time. 
To empower people with Crohn’s 
and Colitis to self-manage their 
condition and make the most out  
of their appointments with 
healthcare professionals.
Please contact publications@crohnsandcolitis.org.uk for more information
Pfizer provided a grant to enable 
the development of the resource 
but had no input into the design 
or content of its production.
Research and focus grouping 
stage.
The Crohn’s & Colitis UK’s 
Publication team, with the 
guidance of patients in the East 
London Local Network. 
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CROHN’S 
AND COLITIS 
COMPANION
10.
People living with Crohn’s Disease 
or Ulcerative Colitis. Useful for  
both newly diagnosed patients 
and those living with the 
condition for some time.
• Guide patients through a user 
journey based on commonly 
asked questions.
•  Provide reliable, accurate and 
trustworthy answers to these 
questions.
• Provide information  
in a wide range of  
formats, including videos  
and animations.
Patients will be better informed 
about all aspects of their care, 
including how to self-manage 
their symptoms and choose 
between drug treatment options.
To give people with Crohn’s and 
Colitis all the information they 
need to manage their condition 
in an accessible, user-friendly 
way. The tool streamlines reliable 
and relevant information, helping 
patients get answers, access 
support and take control.
Resource can be viewed at companion.crohnsandcolitis.org.uk 
Please contact publications@crohnsandcolitis.org.uk for more information
AbbVie provided an educational 
grant to enable the development 
of the website but had no input 
into the design or content of its 
production.
Live product, in constant 
development and continuously 
adding new resources. 
Crohn’s & Colitis UK’s Publication 
team have produced the 
information in the resource in 
partnership with IBD doctors, 
nurses and other specialists as 
well as patients.
The Companion interface was 
created by specialist designers 
and the Crohn’s & Colitis UK 
Digital team. 
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RCGP AND CROHN’S 
AND COLITIS UK 
INFLAMMATORY 
BOWEL DISEASE 
SPOTLIGHT PROJECT
11.
GPs, GP trainees, 
practice nurses, community 
pharmacists, and A&E staff.
• By producing an online toolkit www.
rcgp.org.uk/ibd accessible to GPs and 
patients
•  By speaking to GPs at national 
and regional GP education events, 
promoting the toolkit, developing 
pathways across primary and 
secondary care, and through the use 
of Regional Champions to promote 
the Project in a more localised way 
across 
the UK. 
•  By the production of a free eLearning 
module for healthcare professionals 
www.elearning.rcgp.org.uk/ibd, 
and by facilitating the introduction of 
greater awareness of IBD into the 
postgraduate GP training curriculum.
Increased awareness of IBD and 
diagnostic pathways will speed 
the diagnosis of patients. An 
earlier diagnosis may improve the 
response to treatment. Greater 
awareness of the impact of IBD 
and the support systems available 
for patients will improve care for 
those diagnosed. Topics include: 
extra-intestinal symptoms, 
psychological, educational 
and employment impacts, 
increased risk of bowel cancer, 
osteoporosis, IBD in pregnancy 
and the appropriate use of  
oral steroids.
Half of GPs surveyed lack 
confidence in managing patients 
with IBD. The Spotlight Project 
aims to increase awareness of 
IBD and provide GPs with tool to 
diagnose and support patients.
www.rcgp.org.uk/ibd | www.elearning.rcgp.org.uk/ibd 
@DrBarrettHVCCG | kevin.barrett@nhs.net
The project is funded 
by Crohn’s and Colitis UK and 
runs for a financial year.
The project has just entered the 
second half of its second year.
The steering group is a 
collaboration between the RCGP 
and Crohn’s and Colitis UK. Dr 
Barrett (a GP) is the lead Clinical 
Champion) and Rachel Fowler is 
the patient representative. The 
group meets quarterly.
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FLORENCE IBD 
EXCLUSIVE 
ENTERAL 
NUTRITION 
PROTOCOL
13.
Patient and dietitian.
• Implement Florence  
self-management and  
review protocol. 
• Patient uses Florence to input 
key data which allows virtual 
dietetic review only when 
needed. 
• Dietitians only contact patients 
when patients are highlighted 
by Florence  
rather than reviewing everyone 
at clinic.
Improves patient care as it allows 
better self-management, reduces 
clinic appointments and reduces 
overall cost of treatment as 
outcome are easier to achieve.
To assist patient better  
self-managed their IBD and 
reduce dietetic workload on 
routine review of patients. 
Jacqueline Walker
Internally developed in NHS 
Highland but now funded in 
Tayside via national TEC funding.
Live in Highland IBD practice and 
just starting in Tayside.
Dietitians and patients.
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IBD 
SCOTLAND
12.
People who have IBD
Healthcare professionals in IBD 
teams (multiple disciplines).
• Develop relevant digital 
services – information, tracking, 
video conferencing, targeted 
messaging
• Deploy to patients within an 
existing platform (‘VitruCare’), 
available via web and app 
routes. Professionals to access 
the system using caseload 
dashboards, with full drilldown 
to patient level data
•  Evaluate in clinical use across 
several sites within Scotland
•  Improve confidence in self-
management
•  Optimise timeliness of 
interactions between people 
who have IBD and their 
professional care teams
•  Reduce need for some 
outpatient attendances
•  Expedite escalation in 
treatment and/or admission to 
hospital when this is indicated
•  Shorten length of hospital stay, 
by being able to remain in close 
contact post discharge.
Create and test a digital platform, 
providing people who have 
IBD with relevant information, 
tracking and communication tools 
- allowing them to self-manage, 
whilst remaining connected to 
their professional care teams.
Richard.pope@dynamichealthsystems.co.uk
SBRI funded programme of work; 
Phase 1 complete, Phase 2 just 
ending, Phase 3 planned for early 
2019.
Clinical deployment imminent.
Patient engagement and advice at 
scoping/design stages. 
HCP involvement from IBD 
specialist clinical staff at Dundee 
and Inverness. 
Technical development team  
(Dynamic Health Systems).
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GASTROEN-
TEROLOGY 
AI REFERRAL 
PROJECT 
14.
The pilot phase will be rolled 
out across six consultant 
Gastroenterologist at the 
Western General in Edinburgh 
who triage GP referrals.  The 
functionality is being developed 
so that it can scale across other 
specialties.
• Develop an AI engine to 
read and triage GP referral 
letters, using natural language 
processing techniques and 
present this information to the 
triage clinician.
• To use the AI engine to 
identify Urgent Suspected of 
Cancer patients and automate 
the sending of these to the 
appointment booking team.
• To develop an ‘attended 
robot’ to streamline the time 
it takes for a triage clinician to 
downgrade an urgency status 
or return patients to General 
Practice for further assessment 
or tests.  
• Reducing unwarranted clinical 
variation support improved 
consistency of clinical decision making  
and outcomes by reducing clinical 
variation 
• Faster patient triage automating the 
referral triage process for Urgent 
Suspected of Cancer patients is 
estimated to reduce the overall 
Referral to Treatment (RTT) pathway 
by c1-3 days, or ~ 15% of a two week 
wait target 
• Saving clinical time by reducing their 
administrative burden in triaging and 
sending communications to General 
Practice
• Analytics on referral letters will 
provide an additional insights around 
referral practice and referral quality to 
improve referral pathways. 
The project aims to reduce 
unwarranted variation in the 
current Gastroenterology triage 
process and reduce waiting time 
delays for Urgent Suspected  
Cancer patients.   
Ian Arnott, Clinical Lead, Gastroenterology NHS Lothian | Ian.Arnott@nhslothian.scot.
nhs.uk
Peter Lock, Director, Deloitte | plock@deloitte.co.uk
The development of the triage 
pilot for Gastroenterology has 
been funded by NHS Lothian and 
Deloitte.
Further roll out will require 
business case approval. 
Initial results from the proof 
of concept (Winter 2017/18) 
and feasibility testing (Spring 
2018) showed promising results 
in terms of RITA’s ability to 
triage patients with suspected 
cancer, and most likely clinic or 
diagnostic pathway.
RITA is due to enter a pilot phase 
at NHS Lothian in January 2019 
and if successful go live shortly 
after.
Tracey Gillies, Medical Director at 
NHSL is the SRO for the project
The Clinical Lead for the pilot in 
Gastroenterology is Dr Ian Arnott
The project is being managed by 
a Steering Board comprising:
Tracey Gillies - Medical Director 
Susan Goldsmith - Director of 
Finance 
Martin Egan – Director of eHealth
Dr Ian Arnott – Clinical Lead 
Gastroenterology WGH
The work has undertaken in 
conjunction with Deloitte.
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PATIENT APPS 
INTEGRATION 
PROJECT 
(PAPI)
15.
Primarily patients and clinicians, 
through better information 
returned, but prospectively also 
people with a focus on quality 
improvement and also  
NHS managers.
To develop a simple working 
pilot working with a number of 
selected patient apps to be able 
to demonstrate integration and 
use the learnings from the pilot 
to be able to build a generic 
guide for any patient application 
to be able to use to successfully 
and securely interface with 
the Registry to transfer patient 
reported outcomes data.
By complementing and enhancing 
the Registry’s captured clinical 
dataset with patient reported 
data, we will be able to enhance 
the depth and information in 
our reporting, and also intend in 
the future for approved research 
projects to be able to undertake 
reporting on this combined 
dataset.   
To provide a working proof of 
concept / pilot for patient apps to 
securely connect and submit  
patient reported outcomes data  
to the IBD registry.
Please contact Crohn’s and Colitis UK and/ or the IBD Registry for more information.
Initial funding is via the Modern 
Outpatient Programme and a 
grant from Takeda, with a 12 
months development timescale, 
across financial years 2018-19 
and 2019-20 from Crohn’s and 
Colitis UK.
The project has recently (October 
2018) kicked off with its first all 
stakeholders meeting.
Crohn’s and Colitis UK and the 
IBD Registry are together leading 
the project, with involvement 
from patient applications such as 
MyIBDPatient, PatientKnowsBest, 
HealthSuite and CIMS-Infoflex. 
The project is sponsored by 
Takeda.
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